ATE386511T1 - Wirkstoff gegen helicobacter pylori - Google Patents
Wirkstoff gegen helicobacter pyloriInfo
- Publication number
- ATE386511T1 ATE386511T1 AT96942589T AT96942589T ATE386511T1 AT E386511 T1 ATE386511 T1 AT E386511T1 AT 96942589 T AT96942589 T AT 96942589T AT 96942589 T AT96942589 T AT 96942589T AT E386511 T1 ATE386511 T1 AT E386511T1
- Authority
- AT
- Austria
- Prior art keywords
- helicobacter pylori
- active ingredient
- against helicobacter
- ingredient against
- cyclodextrin
- Prior art date
Links
- 241000590002 Helicobacter pylori Species 0.000 title abstract 2
- 229940037467 helicobacter pylori Drugs 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 2
- 239000001116 FEMA 4028 Substances 0.000 abstract 1
- JBRMEFWJFBHUKG-LJGSYFOKSA-N NC(=N)NC[C@H]1CC[C@H](C(O)=O)CC1 Chemical compound NC(=N)NC[C@H]1CC[C@H](C(O)=O)CC1 JBRMEFWJFBHUKG-LJGSYFOKSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 abstract 1
- 229960004853 betadex Drugs 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Biological Depolymerization Polymers (AREA)
- Polyesters Or Polycarbonates (AREA)
- Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP35466095 | 1995-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE386511T1 true ATE386511T1 (de) | 2008-03-15 |
Family
ID=18439052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96942589T ATE386511T1 (de) | 1995-12-22 | 1996-12-20 | Wirkstoff gegen helicobacter pylori |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6444703B1 (de) |
| EP (1) | EP0870500B1 (de) |
| JP (1) | JP3468244B2 (de) |
| KR (1) | KR100332280B1 (de) |
| AT (1) | ATE386511T1 (de) |
| AU (2) | AU1171697A (de) |
| DE (1) | DE69637442T2 (de) |
| DK (1) | DK0870500T3 (de) |
| ES (1) | ES2301171T3 (de) |
| PT (1) | PT870500E (de) |
| TW (2) | TW457086B (de) |
| WO (1) | WO1997023207A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4658306B2 (ja) * | 2000-10-18 | 2011-03-23 | ナガセ医薬品株式会社 | 錠剤用医薬組成物 |
| US7851457B2 (en) * | 2004-01-29 | 2010-12-14 | Innovative Biologics, Inc. | β-Cyclodextrin derivatives |
| US20080234182A1 (en) * | 2007-03-22 | 2008-09-25 | Innovative Biologics, Inc. | Blockers of pore-forming virulence factors and their use as anti-infectives |
| US20070092502A1 (en) * | 2005-09-01 | 2007-04-26 | Allergan, Inc. | Method of Treating Glaucoma |
| DK2003130T3 (da) | 2006-03-10 | 2011-12-12 | Arigen Pharmaceuticals Inc | Nyt pyridinderivat med anti-helicobacter pylori-aktivitet |
| US8715731B2 (en) * | 2006-03-22 | 2014-05-06 | Isp Investments Inc. | Process of reducing the bitter taste of water soluble actives by co-grinding the active with β cyclodextrin |
| BRPI1014314A2 (pt) | 2009-04-09 | 2019-09-24 | Arigen Pharmaceuticals Inc | derivado de tiopiridina, e, composição farmacêutica. |
| WO2021041506A1 (en) * | 2019-08-26 | 2021-03-04 | Kent State University | Rationally designed lawsone derivatives as antimicrobials against multidrug-resistant staphylococcus aureus |
| TW202535382A (zh) * | 2023-11-29 | 2025-09-16 | 南韓商第一藥品股份有限公司 | 包含ｚａｓｔａｐｒａｚａｎ或其醫藥上可接受的鹽之用於幽門螺旋桿菌根除的組成物 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5645454A (en) | 1979-09-20 | 1981-04-25 | Nippon Chemiphar Co Ltd | Cyclohexanecarboxylic acid derivative and its preparation |
| JPS5692261A (en) | 1979-12-26 | 1981-07-25 | Nippon Chemiphar Co Ltd | Novel cyclohexanecarboxylic derivative and its preparation |
| JPS5692260A (en) | 1979-12-26 | 1981-07-25 | Nippon Chemiphar Co Ltd | Cyclohexanecarboxylic ester and its preparation |
| JPS5716856A (en) | 1980-07-04 | 1982-01-28 | Teikoku Chem Ind Corp Ltd | 4-guanidinomethylcyclohexanecarboxylic acid ester and its preparation |
| JPS5716855A (en) | 1980-07-04 | 1982-01-28 | Teikoku Chem Ind Corp Ltd | 4-guanidinomethylcyclohexanecarboxylic acid ester and its preparation |
| JPS5721360A (en) | 1980-07-14 | 1982-02-04 | Teikoku Chem Ind Corp Ltd | Allyl 4-guanidinomethylcyclohexanecarboxylate and its preparation |
| JPS5735556A (en) | 1980-08-08 | 1982-02-26 | Nippon Chemiphar Co Ltd | Preparation of guanidinomethylcyclohexanecarboxylic acid ester |
| JPS5748959A (en) | 1980-09-08 | 1982-03-20 | Nippon Chemiphar Co Ltd | Preparation of cyclohexanecarboxylic acid derivative or its salt |
| JPS5748958A (en) | 1980-09-08 | 1982-03-20 | Nippon Chemiphar Co Ltd | Cyclohexanecarboxylic acid esters and their acid addition salts |
| JPS5748960A (en) | 1980-09-08 | 1982-03-20 | Nippon Chemiphar Co Ltd | Novel cyclohexanecarboxylic acid derivative and its preparation |
| JPS5775920A (en) | 1980-10-29 | 1982-05-12 | Nippon Chemiphar Co Ltd | Noval remedy for peptic ulcer |
| JPS5775921A (en) | 1980-10-29 | 1982-05-12 | Nippon Chemiphar Co Ltd | Noval remedy for peptic ulcer |
| JPS5775922A (en) | 1980-10-29 | 1982-05-12 | Nippon Chemiphar Co Ltd | Novel remedy for peptic ulcer |
| JPS57126462A (en) | 1981-01-29 | 1982-08-06 | Nippon Chemiphar Co Ltd | Novel carboxylic ester and its preparation |
| JPS57122061A (en) | 1981-01-22 | 1982-07-29 | Nippon Chemiphar Co Ltd | Novel cyclohexanecarboxylic acid derivative and its preparation |
| JPS57122062A (en) | 1981-01-22 | 1982-07-29 | Nippon Chemiphar Co Ltd | Novel trans-4-guanidinocyclohexanecarboxylic acid derivative and its preparation |
| JPS57122059A (en) | 1981-01-22 | 1982-07-29 | Nippon Chemiphar Co Ltd | Novel cyclohexanecarboxylic acid derivative and its preparation |
| JPS57122060A (en) | 1981-01-22 | 1982-07-29 | Nippon Chemiphar Co Ltd | Carboxylic acid ester and its preparation |
| JPS57126463A (en) | 1981-01-29 | 1982-08-06 | Nippon Chemiphar Co Ltd | Novel carboxylic ester and its preparation |
| JPS57126461A (en) | 1981-01-29 | 1982-08-06 | Nippon Chemiphar Co Ltd | Novel guanidino compound and its preparation |
| JPS5838250A (ja) * | 1981-09-01 | 1983-03-05 | Teikoku Chem Ind Corp Ltd | 複合体 |
| JPS6254A (ja) | 1985-03-08 | 1987-01-06 | Kanebo Ltd | 新規グアニジノメチルシクロヘキサンカルボン酸誘導体および該化合物を有効成分とする抗潰瘍薬 |
| JPS6330462A (ja) | 1986-07-24 | 1988-02-09 | Taiyo Yakuhin Kogyo Kk | 新規グアニジノメチルベンツアミド誘導体およびそれを有効成分とする抗潰瘍剤 |
| JPS63218652A (ja) | 1987-03-09 | 1988-09-12 | Taiyo Yakuhin Kogyo Kk | 新規グアニジノメチル安息香酸誘導体およびこれを含有する消化性潰瘍治療剤 |
| JPH04217950A (ja) | 1990-03-28 | 1992-08-07 | Asahi Chem Ind Co Ltd | ヒドロキサム酸誘導体および酵素阻害剤ならびに抗潰瘍剤 |
| JP3073006B2 (ja) | 1990-11-28 | 2000-08-07 | 株式会社日立製作所 | 聴覚機能補助装置 |
| AU4993893A (en) * | 1992-07-31 | 1994-03-03 | Neose Pharmaceuticals, Inc. | Compositions for treating and inhibiting gastric and duodenal ulcers |
| JP3150781B2 (ja) | 1992-09-01 | 2001-03-26 | 株式会社資生堂 | 皮膚外用剤 |
| JP3150782B2 (ja) | 1992-09-01 | 2001-03-26 | 株式会社資生堂 | 皮膚外用剤 |
| JP3150780B2 (ja) | 1992-09-01 | 2001-03-26 | 株式会社資生堂 | 皮膚外用剤 |
| EP0585130B1 (de) | 1992-08-27 | 1998-01-28 | Shiseido Company Limited | Äusserliche, auf der Haut anzuwendende Depigmentierungsmittel enthaltende Zusammensetzung |
| GB9221707D0 (en) * | 1992-10-15 | 1992-12-02 | Smithkline Beecham Plc | Pharmaceutical composition |
| DE4339134A1 (de) * | 1993-11-16 | 1995-05-18 | Bayer Ag | 1-(2-Fluorcyclopropyl)-chinolon- und -naphthyridoncarbonsäure-Derivate |
| JP3796612B2 (ja) * | 1994-02-18 | 2006-07-12 | ナガセケムテックス株式会社 | 抗菌剤 |
| AUPM456894A0 (en) * | 1994-03-18 | 1994-04-14 | Glyzinc Pharmaceuticals Limited | Treatment for gastric disorders |
| DE69519581T2 (de) * | 1994-08-30 | 2001-05-31 | Teikoku Chemical Industry Co., Ltd. | Guanidylmethyl cyclohexancarbonsäure ester derivate |
| JP3046288B1 (ja) | 1998-12-28 | 2000-05-29 | 京セラ株式会社 | 半導体・液晶製造装置用部材 |
-
1996
- 1996-12-20 US US09/091,588 patent/US6444703B1/en not_active Expired - Fee Related
- 1996-12-20 PT PT96942589T patent/PT870500E/pt unknown
- 1996-12-20 DE DE69637442T patent/DE69637442T2/de not_active Expired - Fee Related
- 1996-12-20 DK DK96942589T patent/DK0870500T3/da active
- 1996-12-20 AU AU11716/97A patent/AU1171697A/en not_active Abandoned
- 1996-12-20 KR KR1019980704583A patent/KR100332280B1/ko not_active Expired - Fee Related
- 1996-12-20 US US09/091,588 patent/US20020123508A1/en active Granted
- 1996-12-20 JP JP52350197A patent/JP3468244B2/ja not_active Expired - Fee Related
- 1996-12-20 AT AT96942589T patent/ATE386511T1/de not_active IP Right Cessation
- 1996-12-20 EP EP96942589A patent/EP0870500B1/de not_active Expired - Lifetime
- 1996-12-20 ES ES96942589T patent/ES2301171T3/es not_active Expired - Lifetime
- 1996-12-20 WO PCT/JP1996/003723 patent/WO1997023207A1/ja not_active Ceased
-
1997
- 1997-01-20 TW TW085115861A patent/TW457086B/zh not_active IP Right Cessation
- 1997-01-20 TW TW090111426A patent/TWI225786B/zh not_active IP Right Cessation
-
2001
- 2001-02-12 AU AU19709/01A patent/AU763893C/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69637442T2 (de) | 2008-05-21 |
| PT870500E (pt) | 2008-05-07 |
| TW457086B (en) | 2001-10-01 |
| US20020123508A1 (en) | 2002-09-05 |
| ES2301171T3 (es) | 2008-06-16 |
| AU1171697A (en) | 1997-07-17 |
| AU1970901A (en) | 2001-04-26 |
| EP0870500A4 (de) | 2001-09-12 |
| WO1997023207A1 (en) | 1997-07-03 |
| EP0870500B1 (de) | 2008-02-20 |
| AU763893C (en) | 2004-06-03 |
| EP0870500A1 (de) | 1998-10-14 |
| JP3468244B2 (ja) | 2003-11-17 |
| DK0870500T3 (da) | 2008-06-09 |
| TWI225786B (en) | 2005-01-01 |
| DE69637442D1 (de) | 2008-04-03 |
| AU763893B2 (en) | 2003-07-31 |
| US6444703B1 (en) | 2002-09-03 |
| KR100332280B1 (ko) | 2002-06-20 |
| KR19990072207A (ko) | 1999-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2807195A (en) | Hair growing agent | |
| KR920019342A (ko) | 골질환 치료제 | |
| GB2282327B (en) | Pesticides, insecticides and insect-repellent compositions containing ethanolamine or derivatives thereof | |
| CA2295035A1 (en) | Pharmaceutical formulations containing voriconazole | |
| AU8355998A (en) | Medicinal compositions with cholesterol-lowering effect | |
| KR960702321A (ko) | 용해제 및 이 용해제를 함유하는 외용제제 (solvent and external preparations containing the same) | |
| FR2774288B1 (fr) | Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques | |
| FI945839L (fi) | Bentsotiofeeniyhdisteiden ja vesiliukoisten syklodekstriinien inkluusiokompleksien vesipitoinen liuos ja niiden farmaseuttiset formulaatiot sekä menetelmä | |
| FI911863A7 (fi) | Metyleenidifosfonihappoyhdiste ja tulehdusta estävä aine, joka sisältä ä tätä yhdistettä tehokomponenttina | |
| ATE386511T1 (de) | Wirkstoff gegen helicobacter pylori | |
| NL1002883A1 (nl) | Combinatie-apparaat voor verzorging van tuin, landschap of boerderij. | |
| FI103860B1 (fi) | Glutaarialdehydiä ja 1,2-bentsisotiatsolin-3-onia sisältävä, vesipitoinen biosidinen koostumus ja menetelmä vesipohjaisen koostumuksen suojaamiseksi biologiselta kontaminaatiolta | |
| MA23044A1 (fr) | Derives insecticides de 2,4-dianinopyrimidines-5-substitues. | |
| AU7281094A (en) | Fuming, hot-vaporizing insecticide for killing flies, and method for killing flies with the same | |
| AU6134896A (en) | Resolution of 1-azabicyclo{2.2.2}octan-3-amine, 2-(diphenylmethyl)-n -{{2-methoxy-5-(1-methylethyl)phenyl}methyl} | |
| ATE211383T1 (de) | Topische aciclovir-zubereitung | |
| ES2184121T3 (es) | Formulacion para el tratamiento y/o profilaxis de la demencia. | |
| DK0647401T3 (da) | Pesticide fremgangsmåder og midler | |
| ATE185680T1 (de) | Feste insectizide formulierung | |
| AU4287500A (en) | Animal litter | |
| EP0729950A4 (de) | Anti-hiv arzneimittel | |
| ITRM950421A0 (it) | 17-idrossiimminoalchil e 17-idrossiimminometilalchenil ciclopentaperidrofenantreni attivi sul sistema cardiovascolare, procedimento per la loro preaparazione e composizioni farmaceutiche che li contengono. | |
| DE60017450D1 (de) | Pharmazeutische formulierungen enthaltend salmeterol | |
| AU4166599A (en) | Glucopyranose derivatives and preventives and/or remedies for hiv infection containing the same as the active ingredient | |
| ITRM930546A0 (it) | Nuovi derivati imidazolici, procedimento per la loro preparazione e loro applicazione come pesticidi. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0870500 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |